We are thrilled to have BrainFutures as a sponsor of our next RAMHT event on May 18th at #APA in #LosAngeles!? Excited to continue the conversation around Psychedelic Medicine at our next meeting! #mentalhealth #psychedelicmedicine #patientaccess
BrainFutures and University of California, Berkeley's Collaborative for the Economics of Psychedelics (CEP) are proud to announce the release of our groundbreaking whitepaper: "Scaling Psychedelic Therapies in the Health System." Our survey of mental health #providers across 15 states reveals significant interest in adopting psychedelic therapies alongside challenges.?To tackle some of these challenges, we are #convening providers from across the country on April 1st, 2025 (link to register in the comments). Key Findings Include: ?? Strong Interest in Psychedelic Therapy Expansion: Two-thirds plan to expand psychedelic therapy services, and half expect to offer new psychedelic treatments within six months of FDA approval. ?? Cash-Pay Dominance: Most providers rely on cash-pay models for psychedelic therapy, with little expectation of insurance coverage. This raises concerns about #access and equity, given the expected high out-of-pocket costs of psychedelic therapy. ?? Mission-Driven, Not Profit-Driven: Providers cite a commitment to #patient care as the primary motivator for offering psychedelic therapies rather than financial incentives. Read the full report now to learn more: https://lnkd.in/e7EPqKU6 #psychedelictherapy #healthcare #mentalhealth #healthsystem #psychedelics #access #psychedelicmedicine? Sarah Norman Jazz Glastra Brandon Truax, MS, MBA Elliot Marseille Owen M.